Regeneron Pharmaceuticals, Inc. v. Merus N.V.
REGENERON PHARMACEUTICALS, INC., Plaintiff-Appellant v. MERUS N v. Defendant-Appellee
Attorneys
Neal Kumar Katyal, Hogan Lovells US LLP, Washington, DC, filed a petition for rehearing en banc for plaintiff-appellant. Also represented by William David Maxwell; Thomas Schmidt, New York, NY; Christopher P. Borello, Michael Enzo Furrow, Brendan M. O’Malley, Robert Seth Schwartz, Fitzpatrick, Celia, Harper & Scinto, New York, NY., Patricia A. Carson, Kirkland & Ellis LLP, New York, NY, filed a response to the petition for defendant-appellee. Also represented by Saunak Desai, Aaron D. Resetarits, David N. -Draper; John C. O’Quinn,-Washington, DC; Peter B. Sil-verman, Merus US, Inc., Cambridge, MA., Kevin Edward Noonan, McDonnell, Boehnen, Hulbert & Berghoff, LLP, Chicago, IL, for amicus curiae Seven Chicago Patent Lawyers. Also represented by Jeffrey Palmer Armstrong, Aaron Vincent Gin, James Lee Lovsin, Jeremy E. Noe, Andrew W. Williams, Donald Louis Zuhn, Jr., Richard Abbott Samp, Washington Legal Foundation, Washington, DC, for' amicus curiae Washington Legal Foundation., Edward David Manzo, Husch Blackwell LLP, .Chicago, IL, for amicus curiae Intellectual Property Law Association of Chicago.. Also represented by Robert H. Resis, Banner & Witcoff, Ltd., Chicago, IL., Melissa A. Brand, Biotechnology Innovation Organization, Washington, DC, for amicus curiae Biotechnology Innovation Organization. Also represented by Hans-jorg Sauer; Brian-Paul Barrett, Eli Lilly and Company, Indianapolis, IN., Aaron Russell Fischer, Patterson Belk-nap Webb & Tyler LLP, New York, NY, for amicus curiae New York Intellectual Property Law Association. Also represented by Annemarie Hassett, NYU School of Law, New York, NY; Robert Joseph Ran-do, The Rando Law Firm, P.C., Syosset, NY., Michael Edward McCabe, Jr., McCabe Law LLC, Potomac, MD, for amici curiae David Hricik, Michael Edward .McCabe, Jr.
Full Opinion (html_with_citations)
NEWMAN, Circuit Judge, with whom REYNA, Circuit Judge, joins, dissents from the denial of the petition for rehearing en banc.
ON PETITION FOR REHEARING EN BANC
ORDER
A combined petition for panel rehearing and rehearing en banc was filed by appellant Regeneron Pharmaceuticals, Inc., and a response thereto was invited by the court and filed by appellee Merus N.V. Several motions for leave to file amici curiae briefs were also filed and granted by the court. The petition for rehearing and amici curiae briefs were first referred to the panel that heard the appeal, and thereafter, the petition for rehearing, response, and amici curiae briefs were referred to the circuit judges who are in regular active service. A poll was requested, taken, and failed.
Upon consideration thereof,
It Is Ordered That:
The petition for panel rehearing is denied.
The petition for rehearing en banc is denied.
The mandate of the court will issue on January 2, 2018.